Found 29 matching trials
Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer PHASE1 The purpose of this study the safety and effectiveness of oral AT-101 when ...
Show More Location
Multiple Locations
Learn More & Join Trial
Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer PHASE2 To evaluate a new treatment approach for adults with advanced laryngeal can...
Show More Location
University of Michigan Comprehensive Cancer Center
Learn More & Join Trial
Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations PHASE2 Advanced stage lung cancer is generally treated with anti-cancer medication...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery PHASE1 This phase I trial is studying the side effects and best dose of gossypol w...
Show More Location
Cancer Institute of New Jersey
Learn More & Join Trial
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery PHASE2 This phase II trial is studying how well gossypol acetic acid works in trea...
Show More Location
University of Southern California
Learn More & Join Trial
An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer PHASE1 This is a Phase 1/ 2, open-label, single-center study of preoperative chemo...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme PHASE2 This phase II trial is studying how well gossypol works in treating patient...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies PHASE2 This is an open-label, multicenter, phase II study to evaluate the safety a...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma PHASE2 This is a phase II clinical trial in patients who have not received systemi...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia PHASE2 This is an open-label Phase 2 study to evaluate the safety and efficay of A...
Show More Location
UCSD Moores Cancer Center
Learn More & Join Trial